|Mr. Anthony John Durkacz||Founder & Exec. Co-Chairman||N/A||N/A||1976|
|Dr. Raza Bokhari M.B.A., MBA||MD, Exec. Co-Chairman & CEO||1||N/A||1968|
|Mr. Zeeshan Saeed||Founder, Pres & Director||604.92k||N/A||1971|
|Mr. Donal Carroll CPA||Chief Financial Officer||58.67k||N/A||1977|
|Ms. Sandy Huard||Head of Communications & Investor Relation||N/A||N/A||N/A|
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. FSD Pharma Inc. has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products. The company is headquartered in Cobourg, Canada.
FSD Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.